Trial
NCT03005015
Lenvatinib in Second Line Endometrial Carcinoma
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Collaborators
—
Condition
Endometrial Neoplasms
Intervention
Lenvatinib
Why stopped
supporting company (Eisai) withdrew their interest
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-12-29